1. Home
  2. OBIO vs NMP Comparison

OBIO vs NMP Comparison

Compare OBIO & NMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • NMP
  • Stock Information
  • Founded
  • OBIO 2017
  • NMP 2024
  • Country
  • OBIO United States
  • NMP United States
  • Employees
  • OBIO N/A
  • NMP N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • NMP Blank Checks
  • Sector
  • OBIO Health Care
  • NMP Finance
  • Exchange
  • OBIO Nasdaq
  • NMP Nasdaq
  • Market Cap
  • OBIO 172.1M
  • NMP 158.8M
  • IPO Year
  • OBIO N/A
  • NMP 2025
  • Fundamental
  • Price
  • OBIO $4.00
  • NMP $10.00
  • Analyst Decision
  • OBIO Strong Buy
  • NMP
  • Analyst Count
  • OBIO 4
  • NMP 0
  • Target Price
  • OBIO $14.00
  • NMP N/A
  • AVG Volume (30 Days)
  • OBIO 351.1K
  • NMP 42.9K
  • Earning Date
  • OBIO 11-11-2025
  • NMP 01-01-0001
  • Dividend Yield
  • OBIO N/A
  • NMP N/A
  • EPS Growth
  • OBIO N/A
  • NMP N/A
  • EPS
  • OBIO N/A
  • NMP N/A
  • Revenue
  • OBIO $2,944,000.00
  • NMP N/A
  • Revenue This Year
  • OBIO $29.26
  • NMP N/A
  • Revenue Next Year
  • OBIO $10.65
  • NMP N/A
  • P/E Ratio
  • OBIO N/A
  • NMP N/A
  • Revenue Growth
  • OBIO 41.61
  • NMP N/A
  • 52 Week Low
  • OBIO $2.20
  • NMP $9.90
  • 52 Week High
  • OBIO $6.50
  • NMP $10.00
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 67.99
  • NMP N/A
  • Support Level
  • OBIO $3.53
  • NMP N/A
  • Resistance Level
  • OBIO $4.04
  • NMP N/A
  • Average True Range (ATR)
  • OBIO 0.33
  • NMP 0.00
  • MACD
  • OBIO 0.07
  • NMP 0.00
  • Stochastic Oscillator
  • OBIO 94.20
  • NMP 0.00

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About NMP NMP Acquisition Corp. Class A Ordinary Shares

NMP Acquisition Corp is a blank check company.

Share on Social Networks: